{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:42:25Z","timestamp":1791978145336,"version":"4.4.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"(NIDDKD)"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK061010"],"award-info":[{"award-number":["U01 DK061010"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK061034"],"award-info":[{"award-number":["U01 DK061034"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK061042"],"award-info":[{"award-number":["U01 DK061042"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK061058"],"award-info":[{"award-number":["U01 DK061058"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK085461"],"award-info":[{"award-number":["U01 DK085461"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK085465"],"award-info":[{"award-number":["U01 DK085465"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK085466"],"award-info":[{"award-number":["U01 DK085466"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK085476"],"award-info":[{"award-number":["U01 DK085476"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK085499"],"award-info":[{"award-number":["U01 DK085499"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK085509"],"award-info":[{"award-number":["U01 DK085509"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK103180"],"award-info":[{"award-number":["U01 DK103180"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK103153"],"award-info":[{"award-number":["U01 DK103153"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK103266"],"award-info":[{"award-number":["U01 DK103266"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK103282"],"award-info":[{"award-number":["U01 DK103282"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK106984"],"award-info":[{"award-number":["U01 DK106984"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK106994"],"award-info":[{"award-number":["U01 DK106994"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK107013"],"award-info":[{"award-number":["U01 DK107013"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 DK107014"],"award-info":[{"award-number":["U01 DK107014"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UC4 DK106993"],"award-info":[{"award-number":["UC4 DK106993"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UC4 DK117009"],"award-info":[{"award-number":["UC4 DK117009"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008664","name":"Juvenile Diabetes Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017726","name":"Diabetes Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Essentially all individuals with multiple autoantibodies will develop clinical type 1 diabetes. Multiple autoantibodies (AABs) and normal glucose tolerance define stage 1 diabetes; abnormal glucose tolerance defines stage 2. However, the rate of progression within these stages is heterogeneous, necessitating personalized risk calculators to improve clinical implementation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We developed 3 models using TrialNet's Pathway to Prevention data to accommodate the reality that not all risk variables are clinically available. The small model included AAB status, fasting glucose, hemoglobin A1c, and age, while the medium and large models added predictors of disease progression measured via oral glucose tolerance testing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>All models markedly improved granularity regarding personalized risk missing from current categories of stages of type 1 diabetes. Model-derived risk calculations are consistent with the expected reduction of risk with increasing age and increase in risk with higher glucose and lower insulin secretion, illustrating the suitability of the models. Adding glucose and insulin secretion data altered model predicted probabilities within stages. In those with high 2-hour glucose, a high C-peptide markedly decreased predicted risk; a lower C-peptide obviated the age-dependent risk of 2-hour glucose alone, providing a more nuanced estimate of the rate of disease progression within stage 2.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>While essentially all those with multiple AABs will develop type 1 diabetes, the rate of progression is heterogeneous and not explained by any individual single risk variable. The model-based probabilities developed here provide an adaptable personalized risk calculator to better inform decisions about how and when to monitor disease progression in clinical practice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae292","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T07:52:01Z","timestamp":1715068321000},"page":"3211-3219","source":"Crossref","is-referenced-by-count":12,"title":["Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes"],"prefix":"10.1210","volume":"109","author":[{"given":"Stephan","family":"Pribitzer","sequence":"first","affiliation":[{"name":"Center for Interventional Immunology, Benaroya Research Institute , Seattle, WA 98101 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"O\u2019Rourke","sequence":"additional","affiliation":[{"name":"Center for Interventional Immunology, Benaroya Research Institute , Seattle, WA 98101 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Ylescupidez","sequence":"additional","affiliation":[{"name":"Center for Interventional Immunology, Benaroya Research Institute , Seattle, WA 98101 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Smithmyer","sequence":"additional","affiliation":[{"name":"Center for Interventional Immunology, Benaroya Research Institute , Seattle, WA 98101 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bender","sequence":"additional","affiliation":[{"name":"Center for Interventional Immunology, Benaroya Research Institute , Seattle, WA 98101 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1480-4272","authenticated-orcid":false,"given":"Cate","family":"Speake","sequence":"additional","affiliation":[{"name":"Center for Interventional Immunology, Benaroya Research Institute , Seattle, WA 98101 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3508-0402","authenticated-orcid":false,"given":"Sandra","family":"Lord","sequence":"additional","affiliation":[{"name":"Center for Interventional Immunology, Benaroya Research Institute , Seattle, WA 98101 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4451-9800","authenticated-orcid":false,"given":"Carla J","family":"Greenbaum","sequence":"additional","affiliation":[{"name":"Center for Interventional Immunology, Benaroya Research Institute , Seattle, WA 98101 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"issue":"10","key":"2024111804005492700_dgae292-B1","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American diabetes association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"issue":"3","key":"2024111804005492700_dgae292-B2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00125-015-3830-2","article-title":"Type 1 diabetes TrialNet study Group. The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes","volume":"59","author":"Bingley","year":"2016","journal-title":"Diabetologia"},{"issue":"7","key":"2024111804005492700_dgae292-B3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"2024111804005492700_dgae292-B4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/db20-1112","article-title":"A key to T1D prevention: screening and monitoring relatives as part of clinical care","volume":"70","author":"Greenbaum","year":"2021","journal-title":"Diabetes"},{"issue":"4","key":"2024111804005492700_dgae292-B5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1399-5448.2011.00829.x","article-title":"Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies","volume":"13","author":"Winkler","year":"2012","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"2024111804005492700_dgae292-B6","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00125-023-05953-0","article-title":"Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation","volume":"66","author":"Hummel","year":"2023","journal-title":"Diabetologia"},{"issue":"12","key":"2024111804005492700_dgae292-B7","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00125-022-05780-9","article-title":"Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening","volume":"65","author":"Weiss","year":"2022","journal-title":"Diabetologia"},{"issue":"7","key":"2024111804005492700_dgae292-B8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00125-017-4258-7","article-title":"Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility","volume":"60","author":"Pollanen","year":"2017","journal-title":"Diabetologia"},{"issue":"6","key":"2024111804005492700_dgae292-B9","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s00125-018-4591-5","article-title":"Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study","volume":"61","author":"Long","year":"2018","journal-title":"Diabetologia"},{"issue":"5","key":"2024111804005492700_dgae292-B10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2337\/dc14-2426","article-title":"Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: the environmental determinants of diabetes in the young (TEDDY)","volume":"38","author":"Steck","year":"2015","journal-title":"Diabetes Care"},{"issue":"8","key":"2024111804005492700_dgae292-B11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41591-020-0930-4","article-title":"A combined risk score enhances prediction of type 1 diabetes among susceptible children","volume":"26","author":"Ferrat","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"2024111804005492700_dgae292-B12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/clinem\/dgac594","article-title":"Risk modeling to reduce monitoring of an autoantibody-positive population to prevent DKA at type 1 diabetes diagnosis","volume":"108","author":"O'Rourke","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024111804005492700_dgae292-B13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2337\/dc19-1731","article-title":"Autoantibody reversion: changing risk categories in multiple-autoantibody-positive individuals","volume":"43","author":"So","year":"2020","journal-title":"Diabetes Care"},{"issue":"4","key":"2024111804005492700_dgae292-B14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00125-021-05647-5","article-title":"Characterising the age-dependent effects of risk factors on type 1 diabetes progression","volume":"65","author":"So","year":"2022","journal-title":"Diabetologia"},{"key":"2024111804005492700_dgae292-B15","author":"Gabry"},{"key":"2024111804005492700_dgae292-B16","author":"Stan Development Team"},{"issue":"10","key":"2024111804005492700_dgae292-B17","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.2337\/dc22-0828","article-title":"Rising hemoglobin A1c in the nondiabetic range predicts progression of type 1 diabetes as well as oral glucose tolerance tests","volume":"45","author":"Vehik","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"2024111804005492700_dgae292-B18","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2337\/db14-0497","article-title":"Hba1c predicts time to diagnosis of type 1 diabetes in children at risk","volume":"64","author":"Helminen","year":"2015","journal-title":"Diabetes"},{"issue":"8","key":"2024111804005492700_dgae292-B19","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00125-015-3621-9","article-title":"OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis","volume":"58","author":"Helminen","year":"2015","journal-title":"Diabetologia"},{"issue":"8","key":"2024111804005492700_dgae292-B20","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/pedi.13413","article-title":"Hba1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children","volume":"23","author":"Salami","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"2024111804005492700_dgae292-B21","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.2337\/dc11-0641","article-title":"Validation of the diabetes prevention trial-type 1 risk score in the TrialNet natural history study","volume":"34","author":"Sosenko","year":"2011","journal-title":"Diabetes Care"},{"issue":"11","key":"2024111804005492700_dgae292-B22","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2337\/dc17-0916","article-title":"Dysglycemia and Index60 as prediagnostic end points for type 1 diabetes prevention trials","volume":"40","author":"Nathan","year":"2017","journal-title":"Diabetes Care"},{"key":"2024111804005492700_dgae292-B23","doi-asserted-by":"crossref","unstructured":"Speake C, Pribitzer S, Greenbaum CJ, et al 2024. Supplemental materials for \u201cBeyond stages: predicting individual time dependent risk for type 1 diabetes\u201d. Figshare. 2024. 10.6084\/m9.figshare.25546432.v1.","DOI":"10.1210\/clinem\/dgae292"},{"issue":"8","key":"2024111804005492700_dgae292-B24","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1210\/jc.2017-00569","article-title":"Impact of age and antibody type on progression from single to multiple autoantibodies in type 1 diabetes relatives","volume":"102","author":"Bosi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024111804005492700_dgae292-B25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00125-014-3443-1","article-title":"Progression from single to multiple islet autoantibodies ofter occurs soon after seroconversion: implications for early screening","volume":"58","author":"Chimel","year":"2015","journal-title":"Diabetologia"},{"issue":"4","key":"2024111804005492700_dgae292-B26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jama.2019.21565","article-title":"Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany","volume":"323","author":"Ziegler","year":"2020","journal-title":"JAMA"},{"issue":"15","key":"2024111804005492700_dgae292-B27","doi-asserted-by":"crossref","first-page":"e120877","DOI":"10.1172\/jci.insight.120877","article-title":"Beta cell dysfunction exists more than 5 years before type 1 diabetes diagnosis","volume":"3","author":"Evans-Molina","year":"2018","journal-title":"JCI Insight"},{"issue":"9","key":"2024111804005492700_dgae292-B28","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2337\/dc18-0087","article-title":"A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"2024111804005492700_dgae292-B29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2337\/dc13-2359","article-title":"Use of the diabetes prevention trial-type 1 risk score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes","volume":"37","author":"Sosenko","year":"2014","journal-title":"Diabetes Care"},{"issue":"2","key":"2024111804005492700_dgae292-B30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2337\/dc21-0944","article-title":"Index60 identifies individuals at appreciable risk for stage 3 among an autoantibody-positive population with normal 2-hour glucose levels: implications for current staging criteria of type 1 diabetes","volume":"45","author":"Nathan","year":"2022","journal-title":"Diabetes Care"},{"issue":"9","key":"2024111804005492700_dgae292-B31","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.2337\/dc13-0425","article-title":"The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients","volume":"36","author":"Sosenko","year":"2013","journal-title":"Diabetes Care"},{"issue":"12","key":"2024111804005492700_dgae292-B32","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1210\/jc.2017-01713","article-title":"Assessment of beta cell mass and function by AIRmax and intravenous glucose in high-risk subjects for type 1 diabetes","volume":"102","author":"Hao","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024111804005492700_dgae292-B33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF00408476","article-title":"Natural history of preclinical IDDM in high risk siblings. Childhood diabetes in Finland study group","volume":"37","author":"Knip","year":"1994","journal-title":"Diabetologia"},{"issue":"2","key":"2024111804005492700_dgae292-B34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1067\/mpd.2001.111274","article-title":"First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes","volume":"138","author":"Chase","year":"2001","journal-title":"J Pediatr"},{"issue":"1","key":"2024111804005492700_dgae292-B35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpeds.2006.09.033","article-title":"Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing","volume":"150","author":"Barker","year":"2007","journal-title":"J Pediatr"},{"issue":"3","key":"2024111804005492700_dgae292-B36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-15-0674","article-title":"Reduced beta-cell function in early preclinical type 1 diabetes","volume":"174","author":"Koskinen","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2024111804005492700_dgae292-B37","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00125-016-3924-5","article-title":"The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet pathway to prevention participants","volume":"59","author":"Meah","year":"2016","journal-title":"Diabetologia"},{"issue":"1","key":"2024111804005492700_dgae292-B38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00125-021-05573-6","article-title":"HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet pathway to prevention participants","volume":"65","author":"Felton","year":"2022","journal-title":"Diabetologia"},{"issue":"12","key":"2024111804005492700_dgae292-B39","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1210\/jc.2017-01490","article-title":"The role of age and excess body mass index in progression to type 1 diabetes in at-risk adults","volume":"102","author":"Ferrara","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2024111804005492700_dgae292-B40","author":"NIDDK"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae292\/57570038\/dgae292.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/12\/3211\/60680311\/dgae292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/12\/3211\/60680311\/dgae292.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T04:01:27Z","timestamp":1731902487000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/12\/3211\/7665859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,5,7]]},"published-print":{"date-parts":[[2024,11,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae292","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,5,7]]}}}